GENETIC PROFILE OF ALLOXAN-INDUCED DIABETES SUSCEPTIBLE MICE (ALS) AND ALLOXAN-RESISTANT MICE (ALR)

被引:6
|
作者
SEKIGUCHI, F
ISHIBASHI, K
KATOH, H
KAWAMOTO, Y
INO, T
机构
[1] Research Institute, Daiichi Pharmaceutical Co., Ltd., Tokyo
关键词
D O I
10.1538/expanim1978.39.2_269
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Two inbred strains from a foundation stock derived from Crj: CD-1 (ICR) mice were established after more than 20 generations of full-sib mating, and by simultaneous selective breeding for developing and not developing diabetes after alloxan administration (45 mg/kg in males, 47 mg/kg in females). To elucidate the genetic background of the two inbred strains, i. e., alloxan-induced diabetes-susceptible (ALS) strain and alloxan-induced diabetes-resistant (ALR) strain, their biochemical genetic markers and immunogenetic markers were examined. 1) For both strains, investigation of biochemical genetic markers at 19 loci and immunogenetic markers at 11 loci revealed no variation in any gene within the same strain, showing to be homogeneous, thus indicating establishment of the inbred strains. 2) The two strains differed from each other at 2 loci of biochemical genetic markers and at 5 loci of immunogenetic markers. 3) The ALS and ALR strains can be regarded as new inbred strains derived from ICR mice. 4) The results show that the marker genes of the two strains are different at 7 loci, but it remains unclear whether or not these genes are involved in the difference between the two strains in susceptibility to alloxan.
引用
收藏
页码:269 / 272
页数:4
相关论文
共 50 条
  • [1] Vascular responsiveness in alloxan-induced diabetes-susceptible (ALS) and resistant (ALR) mice
    Abe, A
    Kawazoe, C
    Kondo, Y
    Sato, K
    JOURNAL OF VETERINARY MEDICAL SCIENCE, 1998, 60 (10): : 1119 - 1125
  • [2] Constitutive differences in antioxidant defense status distinguish alloxan-resistant and alloxan-susceptible mice
    Mathews, CE
    Leiter, EH
    FREE RADICAL BIOLOGY AND MEDICINE, 1999, 27 (3-4) : 449 - 455
  • [3] ALLOXAN-INDUCED ANEUPLOIDY IN MICE
    TOLLINGER, CD
    CHRISMAN, CL
    DOOLITTLE, DP
    JOURNAL OF HEREDITY, 1974, 65 (06) : 345 - 348
  • [4] Molecular target structures in alloxan-induced diabetes in mice
    Walde, SSI
    Dohle, C
    Schott-Ohly, P
    Gleichmann, H
    LIFE SCIENCES, 2002, 71 (14) : 1681 - 1694
  • [5] Leukocyte kinetics in the blood of mice with alloxan-induced diabetes
    Kozlov, YA
    Novitskii, VV
    Baikov, AN
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 1995, 119 (07) : 678 - 680
  • [6] EFFECT OF KAMPO MEDICINES ON ALLOXAN-INDUCED DIABETES IN MICE
    STEFEK, M
    OKANIKOVA, L
    BENES, L
    PHARMAZIE, 1994, 49 (10): : 784 - 785
  • [7] ALTERED IMMUNE FUNCTION IN ALLOXAN-INDUCED DIABETES IN MICE
    GLASS, EJ
    STEWART, J
    WEIR, DM
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1986, 65 (03): : 614 - 621
  • [8] PREVENTION OF ALLOXAN-INDUCED DIABETES IN MICE BY DIMETHYL-SULFOXIDE
    HEIKKILA, RE
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1977, 44 (02) : 191 - 193
  • [9] ANTIDIABETIC ACTIVITY OF TEA POLYSACCHARIDES IN MICE WITH ALLOXAN-INDUCED DIABETES
    Liu, Yang
    Li, Shuai
    Cheng, Yingkun
    Li, Chenliang
    Wang, Di
    Yan, Guodong
    JOURNAL OF INVESTIGATIVE MEDICINE, 2016, 64 (08) : A15 - A15
  • [10] PROTECTION AGAINST ALLOXAN-INDUCED DIABETES BY DIETHYLDITHIOCARBAMATE AND DISULFIRAM IN MICE
    MASUKAWA, T
    NAKANISHI, K
    JAPANESE JOURNAL OF PHARMACOLOGY, 1994, 64 (03): : 141 - 146